IMCC
IMCC
NASDAQ · Pharmaceuticals

Im Cannabis Corp

$0.57
-0.03 (-5.09%)
As of Mar 25, 5:31 PM ET ·
Financial Highlights (FY 2026)
Revenue
165.54M
Net Income
-32,430,840
Gross Margin
15.6%
Profit Margin
-19.6%
Rev Growth
+16.6%
D/E Ratio
3.44
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 15.6% 15.6% 43.8% 43.8%
Operating Margin -18.9% -17.0% 16.8% 17.0%
Profit Margin -19.6% -18.6% 13.3% 12.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 165.54M 141.92M 4.60M 5.55M
Gross Profit 25.89M 22.20M 2.01M 2.43M
Operating Income -31,353,401 -24,192,439 771.4K 945.4K
Net Income -32,430,840 -25,023,796 612.3K 695.3K
Gross Margin 15.6% 15.6% 43.8% 43.8%
Operating Margin -18.9% -17.0% 16.8% 17.0%
Profit Margin -19.6% -18.6% 13.3% 12.5%
Rev Growth +16.6% +16.6% +11.5% +14.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.51M 2.51M 7.39M 5.68M
Total Equity 730.2K 730.2K 8.30M 9.81M
D/E Ratio 3.44 3.44 0.89 0.58
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -28,882,435 -23,523,931 960.1K 1.02M
Free Cash Flow 405.9K 317.4K